Delivery Order SPE2DB24D8002-SPE2DB25FJNND
Award Date
4/15/25
Potential Completion Date
4/16/25
Potential Value
$8.5K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product. The contract, which has a firm fixed price of $4,442.65 and an ultimate completion date of January 4, 2024, is part of the DLA Troop Support Medical's ECAT Generation V Program, a large indefinite delivery contract (IDC) valued at $999,999,999.00 that allows Dakota Drug,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract has a ceiling value of $8,785.43 and a performance period ending on June 17, 2024. Dakota Drug, Inc. has also been awarded a larger Indefinite Delivery Contract (IDC) worth $999,999,999.00 under the DLA Troop Support Medical's ECAT Generation V Program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $5,229.84, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, to support medical operations for the U.S. Armed Forces. The contract does not have a set-aside designation and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which allows Dakota...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,272.41 fixed-price contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical product to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of October 19, 2023. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,311.87, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC,...
The U.S. Defense Logistics Agency (DLA) awarded a $6,399.12 firm-fixed-price delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 4566343564 units of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical product. This delivery order falls under Dakota Drug's existing indefinite delivery contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which supports the DLA Troop Support Medical's ECAT Generation V Program. The contract has an ultimate completion date...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract has a ceiling value of $15,991.71 and a period of performance through January 15, 2025. This delivery order was placed under Dakota Drug's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which is part of the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $5,846.07, is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a prescription medication. The contract is a firm fixed-price, non-set-aside delivery order with a performance period ending on February 26, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA). The contract, valued at $8,358.56, is a firm fixed-price delivery order for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S. The award has an ultimate completion date of February 11, 2025. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a range of pharmaceutical and medical products to support U.S. Armed...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,570.36, is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, to support the medical supply chain needs of the U.S. Department of Defense. The contract has a completion date of December 1, 2023, and is a Firm Fixed Price Delivery Order. Dakota Drug, Inc. also holds a larger Indefinite Delivery Contract...